Cholesterol Absorption Inhibitor — Non-Statin LDL Reduction
Ezetimibe is a cholesterol absorption inhibitor — NOT a statin. It works at the intestinal brush border to block dietary and biliary cholesterol uptake, reducing LDL cholesterol without the muscle-related side effects of statins. It is considered non-negotiable lipid support for any oral steroid cycle.
Selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) transporter at the intestinal brush border, blocking the absorption of dietary and biliary cholesterol. This reduces cholesterol delivery to the liver, upregulates hepatic LDL receptors, and lowers circulating LDL-C.
| Parameter | Details |
|---|---|
| Standard Dose | 10 mg daily |
| Dose Adjustment | None needed — single fixed dose |
| Route | Oral — no food timing requirement |
| LDL Reduction | Measurable drop in 2–4 weeks |
Non-Negotiable for Oral Steroid Cycles
Any client running an oral steroid (e.g., Anavar, Turinabol, Dianabol) MUST include Ezetimibe as baseline lipid protection. Oral steroids devastate lipid panels — this is not optional.
Clinical Note
Ezetimibe is one of the best-tolerated lipid medications available. Its non-statin mechanism makes it ideal for clients who experience statin side effects or who need additional LDL reduction on top of a statin.
This guide is for educational and clinical-support purposes only. All dosing must be supervised by a licensed prescriber. Matrix Advanced Solutions does not provide medical advice. Always consult your healthcare provider before starting any peptide protocol.